Heron Therapeutics(HRTX) - 2025 Q3 - Quarterly Results

Exhibit 99.1 Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress CARY, N.C., November 4, 2025 (GLOBE NEWSWIRE) -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and nine months ended September 30, 2025 and recent corporate updates. "There were a number of new initiatives launched in the third quarter, and we're encouraged by the early signs that they're positiv ...